HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

tissue polypeptide specific antigen

Subscribe to New Research on tissue polypeptide specific antigen

do not confuse with TPA antigen (measures a different cytokeratin in serum)

Also Known As:

TPS antigen

Networked: 143 relevant articles (2 outcomes, 21 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins
- Peptides: 22950
  - tissue polypeptide specific antigen: 143

Experts

1.	Luo, Rong-cheng: 5 articles (02/2006 - 02/2003)
2.	Abdulkader, I: 4 articles (03/2009 - 08/2000)
3.	Liska, Vaclav: 3 articles (12/2015 - 03/2009)
4.	Barak, Vivian: 3 articles (10/2015 - 01/2011)
5.	Gonzalez-Quintela, A: 3 articles (03/2009 - 09/2004)
6.	Campos, J: 3 articles (03/2009 - 09/2004)
7.	Einarsson, R: 3 articles (01/2009 - 07/2000)
8.	Zheng, Hang: 3 articles (10/2005 - 02/2003)
9.	Kao, C H: 3 articles (01/2002 - 01/2000)
10.	Holubec, Lubos: 2 articles (12/2015 - 04/2011)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 01/01/2002 - "Role of tissue polypeptide specific antigen in the detection of prostate cancer." 05/01/1993 - "Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer." 01/01/1993 - "Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy." 01/01/2002 - "The aim of the present study was to evaluate the role of tissue polypeptide specific antigen (TPS) in the diagnosis of different stages of prostatic cancer (CaP) and to compare the diagnostic efficacy of serum TPS in respect to total prostate-specific antigen (tPSA) and free/total (f/t) PSA ratio. " 01/01/1997 - "This experimental study investigated the potential role of Tissue Polypeptide-Specific Antigen (TPS) in comparison with Prostate-Specific Antigen (PSA) in the diagnosis and the clinical and pathological staging of prostate cancer. "
2.	Hepatocellular Carcinoma (Hepatoma) 01/01/2011 - "Tissue polypeptide specific antigen is efficient for determining primary hepatoma patients and also that this marker is specific for proliferation of cells." 09/01/2003 - "Our data suggest that tissue polypeptide specific antigen is efficient in determining primary hepatoma patients and also that this marker is specific for proliferation of cells." 07/01/2002 - "Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection." 01/01/2001 - "Clinicopathologic correlation of serum tissue polypeptide specific antigen in hepatocellular carcinoma." 03/01/1999 - "The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma."
3.	Liver Cirrhosis (Hepatic Cirrhosis) 09/01/2003 - "The aim of this study was to evaluate the levels of tissue polypeptide specific antigen and other tumor markers in patients with liver cirrhosis, chronic active hepatitis and hepatoma to determine if tissue polypeptide specific antigen is superior to other tumor markers in hepatoma patients. " 01/01/2011 - "The aim of this study was to evaluate the levels of tissue polypeptide specific antigen and other tumor markers in patients with liver cirrhosis, chronic active hepatitis and hepatoma to determine if tissue polypeptide specific antigen is important to other tumor markers in hepatoma patients. "
4.	Chronic Hepatitis (Chronic Active Hepatitis) 01/01/2011 - "There was a low correlation between tissue polypeptide specific antigen and alpha-fetoprotein in the cirrhotic and hepatoma groups, but these were significantly correlated in the chronic active hepatitis group. " 09/01/2003 - "There was a low correlation between tissue polypeptide specific antigen and alpha-fetoprotein in the cirrhotic and hepatoma groups, but these were significantly correlated in the chronic active hepatitis group. " 09/01/2003 - "The aim of this study was to evaluate the levels of tissue polypeptide specific antigen and other tumor markers in patients with liver cirrhosis, chronic active hepatitis and hepatoma to determine if tissue polypeptide specific antigen is superior to other tumor markers in hepatoma patients. " 01/01/2011 - "The aim of this study was to evaluate the levels of tissue polypeptide specific antigen and other tumor markers in patients with liver cirrhosis, chronic active hepatitis and hepatoma to determine if tissue polypeptide specific antigen is important to other tumor markers in hepatoma patients. "
5.	Neoplasms (Cancer) 01/01/2004 - "[Serum tumor marker TPS (tissue polypeptide-specific antigen)]." 11/01/2002 - "Tissue polypeptide specific antigen (TPS) is a tumor marker that indicates tumor proliferative rate rather than tumor burden. " 09/01/2002 - "Tissue polypeptide specific antigen (TPS) is a new tumor marker that indicates tumor proliferative rate rather than tumor burden. " 11/01/2000 - "Tissue polypeptide specific antigen (TPS) is a new tumor marker that indicates tumor proliferative rate rather than tumor burden. " 08/01/2000 - "Serum tissue polypeptide specific antigen (TPS) is widely used as a tumor proliferation marker. "

Related Drugs and Biologics

1.	Biological Tumor Markers (Tumor Markers)
2.	Prostate-Specific Antigen (Semenogelase)
3.	Carcinoembryonic Antigen
4.	Antigens
5.	Tissue Polypeptide Antigen
6.	Phosphopyruvate Hydratase (Enolase)
7.	Keratins (Keratin)
8.	Thymidine Kinase
9.	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)
10.	Keratin-19 (Keratin 19)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Transplantation (Transplant Recipients)
3.	Radiotherapy
4.	Aftercare (After-Treatment)